Gene · 239
NIH grants1,363
NIH grants whose papers are about the gene, through NIH's grant-paper links.
121 to 140 of 1,363
Download this page as JSON| Grant | Title | ALOX12 papers | Newest fiscal year |
|---|---|---|---|
| R01DK097441 | Molecular mechanisms of UCP1-independent pathways in metabolic health | 1 | 2025 |
| R01DK114356 | Metabolic Impacts of Type II Interferon Signals in Obesity | 1 | 2025 |
| R01DK125283 | Mitochondrial BCAA transporter in physiology and disease | 1 | 2025 |
| R01DK125898 | Insulin Regulation of Hepatic Function via Zone-Specific Transcriptional Programs | 1 | 2025 |
| R01DK127236 | Control of beta cell function and survival by RYR2-mediated calcium signals | 1 | 2025 |
| R01DK127575 | Post-translational control of adipose tissue remodeling and metabolic health | 1 | 2025 |
| R01DK135832 | The Role of Polyamines and Hypusine in Beta-Cell Dysfunction | 1 | 2025 |
| R01ES004738 | Activated Macrophages and Ozone Toxicity | 1 | 2025 |
| R01FD006118 | Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014) | 1 | 2025 |
| R01GM072744 | Bioengineering approaches to map mechanotransduction in the living cell | 1 | 2025 |
| R01GM127791 | Targeting ACOD1 to attenuate innate immune responses to lethal infections | 1 | 2025 |
| R01HD034568 | Prenatal environmental determinants of health in young adulthood: a lifecourse approach | 1 | 2025 |
| R01HD108173 | Transient Vanilloid Receptors and Vulvar Pain: New Therapeutic Targets for Vulvodynia | 1 | 2025 |
| R01HG005853 | Mapping dynamic functional networks across environments and backgrounds | 1 | 2025 |
| R01HL019134 | Angiotensins, Prostaglandins and Adrenergic Interactions | 1 | 2025 |
| R01HL118639 | Regulation of Myocardial Phospholipases and Lipases in Diabetic Myocardium | 1 | 2025 |
| R01HL122477 | Transitions from Impaired Respiratory Health to Lung Disease | 1 | 2025 |
| R01MD011728 | Epigenomic Predictors of PTSD and Traumatic Stress in an African American Cohort | 1 | 2025 |
| R01NS045954 | Neuropeptidergic Inhibition of Spinal Pain Transmission | 1 | 2025 |
| R25MH060482 | TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERS | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/239/grants?page=7